Brian R. Overholser

Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients

James E. Tisdale, Heather A. Jaynes, Joanna R. Kingery et al. · Circulation Cardiovascular Quality and Outcomes · 2013 · 373 citations · Full text

Opioid pharmacokinetic drug-drug interactions.

Brian R. Overholser, David R. Foster · PubMed · 2011 · 122 citations

Potential Ddis, Substance Abuse, Pharmacokinetic Modeling +15

Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients

James E. Tisdale, Heather A. Jaynes, Joanna R. Kingery et al. · Circulation Cardiovascular Quality and Outcomes · 2014 · 88 citations · Full text

Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs

James E. Tisdale, Heather A. Wroblewski, Brian R. Overholser et al. · Drug Safety · 2012 · 82 citations

Heart Failure, Cardiac Anaesthesia, Cardiovascular Disease +12

Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin

Michael Kays, Brian R. Overholser, Bruce A. Mueller et al. · American Journal of Kidney Diseases · 2003 · 82 citations

Oral Bioavailability, Medicine, Sevelamer Hydrochloride +4